Yonder: a diverse selection of primary care relevant research stories from beyond the mainstream biomedical literature

On initiation of a new antidepressant medication, National Institute for Health and Care Excellence guidance suggests a review within 1–2 weeks.1 How likely this is to happen depends on clinician, patient, and system factors. This Norwegian registry-based cohort study of 17 000 patients with a new depression diagnosis starting antidepressants found that 27.8% of patients were followed up within 14 days, 50.9% within 30 days, and 67.1% within 90 days of first drug dispensing.2 Patients who were older or had a lower level of education were less likely to have been followed up at each time point, and also less likely to access talking therapies. …